What was the market valuation for endoscopic retrograde-cholangiopancreatography in 2024?

The market valuation for endoscopic retrograde-cholangiopancreatography was $68.52 Million in 2024. Read More

What is the projected market valuation for 2035?

The projected market valuation for 2035 is $187.78 Million. Read More

What is the expected CAGR for the market during the forecast period 2025 - 2035?

The expected CAGR for the market during the forecast period 2025 - 2035 is 9.6%. Read More

Which companies are considered key players in the market?

Key players in the market include Boston Scientific, Medtronic, Olympus Corporation, Cook Medical, Fujifilm Holdings Corporation, Conmed Corporation, Hoya Corporation, and B. Braun Melsungen AG. Read More

What segment had the highest valuation in the procedure category?

In the procedure category, Biliary Sphincterotomy had the highest valuation, reaching $42.0 Million. Read More

How do hospitals and clinics compare to ambulatory surgical centers in terms of market valuation?

Hospitals and clinics had a market valuation of $110.0 Million, significantly higher than the $77.78 Million for ambulatory surgical centers. Read More

What is the valuation range for Bile Duct applications?

The valuation range for Bile Duct applications is from $27.41 Million to $75.0 Million. Read More

Which product segment is projected to grow the most by 2035?

The Endoscopes product segment is projected to grow the most, with a valuation range of $15.0 Million to $42.0 Million. Read More

What is the valuation for Biliary Stenting in the procedure segment?

The valuation for Biliary Stenting in the procedure segment ranges from $12.0 Million to $35.0 Million. Read More

What does the market data suggest about future growth trends?

The market data suggests a robust growth trend, with a projected increase in valuation from $68.52 Million in 2024 to $187.78 Million by 2035. Read More

Italy Endoscopic Retrograde Cholangiopancreatography Market

ID: MRFR/HC/49841-HCR

200 Pages

Rahul Gotadki

Last Updated: April 02, 2026

Italy Endoscopic Retrograde Cholangiopancreatography Market Research Report: Size, Share, Trend Analysis By Procedure (Biliary Sphincterotomy, Biliary Stenting, Biliary Dilatation, Pancreatic Duct Stenting, Others), By End Users (Hospitals & Clinics, Ambulatory Surgical Centers), By Applications (Bile Duct, Pancreas, Others) andBy Product (Endoscopes, Imaging Devices, Energy Devices) - Growth Outlook & Industry Forecast 2025 To 2035

Italy Endoscopic Retrograde Cholangiopancreatography Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 Chemicals and Materials, BY Procedure (USD Million) | |
  1. 4.1.1 Biliary Sphincterotomy | |
  2. 4.1.2 Biliary Stenting | |
  3. 4.1.3 Biliary Dilatation | |
  4. 4.1.4 Pancreatic Duct Stenting | |
  5. 4.1.5 Others |
2. 4.2 Chemicals and Materials, BY End User (USD Million) | |
  1. 4.2.1 Hospitals & Clinics | |
  2. 4.2.2 Ambulatory Surgical Centers |
3. 4.3 Chemicals and Materials, BY Application (USD Million) | |
  1. 4.3.1 Bile Duct | |
  2. 4.3.2 Pancreas | |
  3. 4.3.3 Others |
4. 4.4 Chemicals and Materials, BY Product (USD Million) | |
  1. 4.4.1 Endoscopes | |
  2. 4.4.2 Endotherapy Devices | |
  3. 4.4.3 Catheters | |
  4. 4.4.4 Stents | |
  5. 4.4.5 Balloons | |
  6. 4.4.6 Guiding Wires | |
  7. 4.4.7 Others | |
  8. 4.4.8 Imaging Devices | |
  9. 4.4.9 Energy Devices 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the Chemicals and Materials | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 Boston Scientific (US) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Medtronic (US) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 Olympus Corporation (JP) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 Cook Medical (US) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 Fujifilm Holdings Corporation (JP) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 Conmed Corporation (US) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 Hoya Corporation (JP) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 B. Braun Melsungen AG (DE) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 ITALY MARKET ANALYSIS BY PROCEDURE |
6. 6.3 ITALY MARKET ANALYSIS BY END USER |
7. 6.4 ITALY MARKET ANALYSIS BY APPLICATION |
8. 6.5 ITALY MARKET ANALYSIS BY PRODUCT |
9. 6.6 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS |
10. 6.7 RESEARCH PROCESS OF MRFR |
11. 6.8 DRO ANALYSIS OF CHEMICALS AND MATERIALS |
12. 6.9 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS |
13. 6.10 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS |
14. 6.11 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS |
15. 6.12 CHEMICALS AND MATERIALS, BY PROCEDURE, 2024 (% SHARE) |
16. 6.13 CHEMICALS AND MATERIALS, BY PROCEDURE, 2024 TO 2035 (USD Million) |
17. 6.14 CHEMICALS AND MATERIALS, BY END USER, 2024 (% SHARE) |
18. 6.15 CHEMICALS AND MATERIALS, BY END USER, 2024 TO 2035 (USD Million) |
19. 6.16 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 (% SHARE) |
20. 6.17 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 TO 2035 (USD Million) |
21. 6.18 CHEMICALS AND MATERIALS, BY PRODUCT, 2024 (% SHARE) |
22. 6.19 CHEMICALS AND MATERIALS, BY PRODUCT, 2024 TO 2035 (USD Million) |
23. 6.20 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
24. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
25. 7.2 Italy MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY PROCEDURE, 2025-2035 (USD Million) | |
  2. 7.2.2 BY END USER, 2025-2035 (USD Million) | |
  3. 7.2.3 BY APPLICATION, 2025-2035 (USD Million) | |
  4. 7.2.4 BY PRODUCT, 2025-2035 (USD Million) |
26. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.3.1 |
27. 7.4 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

Italy Chemicals and Materials Market Segmentation

Chemicals and Materials By Procedure (USD Million, 2025-2035)

Biliary Sphincterotomy
Biliary Stenting
Biliary Dilatation
Pancreatic Duct Stenting
Others

Chemicals and Materials By End User (USD Million, 2025-2035)

Hospitals & Clinics
Ambulatory Surgical Centers

Chemicals and Materials By Application (USD Million, 2025-2035)

Bile Duct
Pancreas
Others

Chemicals and Materials By Product (USD Million, 2025-2035)

Endoscopes
Endotherapy Devices
Catheters
Stents
Balloons
Guiding Wires
Others
Imaging Devices
Energy Devices

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”